Misplaced Pages

Cefpimizole: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editNext edit →Content deleted Content addedVisualWikitext
Revision as of 23:34, 30 June 2011 editCheMoBot (talk | contribs)Bots141,565 edits Updating {{drugbox}} (changes to verified fields - updated 'ChemSpiderID_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEMBL_Ref') per Chem/Drugbox validation (report [[Misplaced Pages talk:WikiProject_Ph← Previous edit Revision as of 22:49, 13 August 2011 edit undoCheMoBot (talk | contribs)Bots141,565 edits Updating {{drugbox}} (no changed fields - added verified revid - updated 'ChemSpiderID_Ref', 'DrugBank_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEBI_Ref') per [[Misplaced Pages:WikiProject Chemicals/Chembox validation|Chem/DrugNext edit →
Line 1: Line 1:
{{drugbox {{drugbox
| UNII_Ref = {{fdacite|correct|FDA}}
| Verifiedfields = changed
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = 24S58UHU7N | UNII = 24S58UHU7N
| verifiedrevid = 402797569 | verifiedrevid = 437136825
| IUPAC_name = 2--2-phenylacetyl]amino)-8-oxo-5-thia-1-azabicyclooct-2-en-3-yl]methyl)pyridin-1-ium-4-yl]ethanesulfonate | IUPAC_name = 2--2-phenylacetyl]amino)-8-oxo-5-thia-1-azabicyclooct-2-en-3-yl]methyl)pyridin-1-ium-4-yl]ethanesulfonate
| image = Cefpimizole.png | image = Cefpimizole.png
Line 13: Line 12:
| ATC_supplemental = | ATC_supplemental =
| PubChem = 68597 | PubChem = 68597
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = | DrugBank =
| KEGG_Ref = {{keggcite|correct|kegg}} | KEGG_Ref = {{keggcite|correct|kegg}}

Revision as of 22:49, 13 August 2011

Pharmaceutical compound
Cefpimizole
Clinical data
ATC code
  • none
Legal status
Legal status
  • In general: ℞ (Prescription only)
Identifiers
IUPAC name
  • 2--2-phenylacetyl]amino)-8-oxo-5-thia-1-azabicyclooct-2-en-3-yl]methyl)pyridin-1-ium-4-yl]ethanesulfonate
CAS Number
PubChem CID
UNII
KEGG
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC28H26N6O10S2
Molar mass670.67 g/mol g·mol
3D model (JSmol)
SMILES
  • C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)NC(=O)C4=C(NC=N4)C(=O)O)C(=O)O) C5=CC=C(C=C5)CCS(=O)(=O)
  (verify)

Cefpimizole (INN) is a third-generation cephalosporin antibiotic.

References

  • Hara K, Shimada J (1987). "". Jpn J Antibiot (in Japanese). 40 (6): 1108–22. PMID 3312705. {{cite journal}}: Unknown parameter |month= ignored (help)
Stub icon

This systemic antibiotic-related article is a stub. You can help Misplaced Pages by expanding it.

Antibacterials active on the cell wall and envelope (J01C-J01D)
β-lactams
(inhibit synthesis
of peptidoglycan
layer of bacterial
cell wall by binding
to and inhibiting
PBPs, a group of
D-alanyl-D-alanine
transpeptidases
)
Penicillins (Penams)
Narrow
spectrum
β-lactamase sensitive
(1st generation)
β-lactamase resistant
(2nd generation)
Extended
spectrum
Aminopenicillins (3rd generation)
Carboxypenicillins (4th generation)
Ureidopenicillins (4th generation)
Other
Carbapenems / Penems
Cephems
Cephalosporins
Cephamycins
Carbacephems
1st generation
2nd generation
3rd generation
4th generation
5th generation
Siderophore
Veterinary
Monobactams
β-lactamase inhibitors
Combinations
Polypeptides
Lipopeptides
Other
  • Inhibits PG elongation and crosslinking: Ramoplanin
Intracellular
Other
Categories: